Since the decision whether a cell undergoes apoptosis depends on the balance between pro- and anti-apoptotic factors like XAF1 and XIAP [18], the concurrent evaluation of these parameters in RCC, represented through the XIAP to XAF ratio, may help to improve the prognostic value of these parameters compared to separate analyses. This evidence concerns the gene XAF1 and renal cell carcinoma.